5-aminolevulinsyre-fluorescens-vejledt resektion af maligne gliomer er en ny behandlingsmodalitet

Ugeskrift for Laeger

Volumn 175, Issue 9, 2013, Pages 570-573

  Cortnum, Søren ^a   Laursen, Rene ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DIAGNOSTIC AGENT; FLUORESCENT DYE; PHOTOSENSITIZING AGENT;

ARTICLE; BRAIN TUMOR; DISEASE FREE SURVIVAL; EVIDENCE BASED MEDICINE; GLIOMA; HUMAN; METHODOLOGY; NEUROSURGERY; PATHOLOGY; TREATMENT OUTCOME;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; FLUORESCENT DYES; GLIOMA; HUMANS; NEUROSURGICAL PROCEDURES; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 84875515225     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Stummer W, Reulen HJ, Meinel T et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62:564-76.
2. Lacroix M, Abi Said D, Fourney DR et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection and survival. J Neurosurg 2001;95:190-8.
3. Stupp R, Mason WP, van den Bent MJ et al. for the European Organization for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups and National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
4. van den Bent MJ, Stupp R, Mason W et al. Impact of the extent of resection on overall survival in newly diagnosed glioblastoma after chemo-irradiation with temozolomide: further analysis of EORTC study 26981. Eur J Cancer Suppl 2005;3:134.
5. Stummer W, Kamp MA. The importance of surgical resection in malignant glioma. Current Opinion in Neurology 2009;22:645-9.
6. Albert FK, Forsting M, Sartor K et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-60.
7. Vecht CJ, Avezaat CJ, van Putten WL et al. The influence of the extent of surgery on the neurological function and survival in malignant glioma. J Neurol Neurosurg Psychiatry 1990;53:466-71.
8. Kowalczuk A, MacDonald RL, Amidei C et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 1997;41:1028-36.
9. Dansk Neuro Onkologisk Register. Årsrapport 2010. www.DNOG.dk.
10. Stummer W, Novotny A, Stepp H et al. Fluorescence-guideed resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000;93:1003-13.
11. Stummer W, Stocker S, Wagner S et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 1998;42:518-25.
12. Gliolan SPC 2007. Product resumé. www.Medac-uk.co.uk.
13. Shinoda J, Yano H, Yoshimura S et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. J Neurosurg 2003;99:597-603.
14. Stummer W, Pichlmeier U, Meinel T et al. for the ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 2006;7:392-401.
15. Stummer W, Tonn JG, Mehdorn HM et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. J Neurosurg 2011;114:613-23.
16. Laws ER, Parney IF, Huang W et al. Survival following surgery and prognostic factors for recently diagnose malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003;99:467-73.
17. Stummer W, Nestler U, Stockhammer F et al. Favorable outcome in the elderly cohort treated by concomitant radiochemotherapy in a multicentric phase II safety study of 5-ALA. J Neurooncol 2011;103:361-70.